Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(3.79)
# 710
Out of 5,140 analysts
472
Total ratings
43.19%
Success rate
11.15%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MIRM Mirum Pharmaceuticals | Reiterates: Buy | $81 → $102 | $93.27 | +9.36% | 4 | Jan 13, 2026 | |
| DCTH Delcath Systems | Reiterates: Buy | $30 | $10.34 | +190.14% | 16 | Jan 9, 2026 | |
| CGEN Compugen | Initiates: Buy | $4 | $2.11 | +89.57% | 1 | Jan 7, 2026 | |
| CORT Corcept Therapeutics | Maintains: Buy | $145 → $90 | $36.31 | +147.87% | 26 | Jan 2, 2026 | |
| EKSO Ekso Bionics Holdings | Downgrades: Neutral | n/a | $7.85 | - | 17 | Dec 31, 2025 | |
| PYXS Pyxis Oncology | Maintains: Buy | $5 → $7 | $1.66 | +321.69% | 11 | Dec 19, 2025 | |
| ABSI Absci | Maintains: Buy | $7 → $8 | $3.02 | +164.90% | 15 | Dec 18, 2025 | |
| JANX Janux Therapeutics | Maintains: Buy | $70 → $45 | $13.27 | +239.11% | 14 | Dec 2, 2025 | |
| MDWD MediWound | Maintains: Buy | $31 → $36 | $17.07 | +110.90% | 20 | Nov 21, 2025 | |
| ACTU Actuate Therapeutics | Reiterates: Buy | $20 | $5.87 | +241.01% | 4 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $4.5 | $0.70 | +542.86% | 8 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $155 | $109.04 | +42.15% | 5 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $77 → $94 | $107.16 | -12.28% | 11 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8.5 → $9 | $4.47 | +101.34% | 14 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $32 | $18.08 | +76.99% | 16 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $9.65 | +34.72% | 19 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $47 | $48.03 | -2.14% | 8 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3.5 → $5 | $3.75 | +33.33% | 18 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $7,500 | $4.08 | +183,723.53% | 1 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $1.81 | +176.24% | 18 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $22 | $6.60 | +233.33% | 2 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $3 | $0.89 | +237.76% | 1 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $4.18 | +282.78% | 14 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.41 | +680.14% | 12 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $15 | $2.76 | +443.48% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $0.98 | +206.12% | 2 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.49 | +369.80% | 22 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $35 | $15.17 | +130.72% | 8 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $1.23 | - | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.00 | +200.72% | 3 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $1.47 | +36.05% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $1.54 | +127.27% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $3.68 | +416.30% | 14 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $180 | $2.33 | +7,625.32% | 15 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $7.58 | +229.82% | 13 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $37.72 | +59.07% | 18 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $6.90 | +378.26% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.40 | +1,159.45% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $5.33 | +106.38% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $5.57 | +259.07% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $6.16 | +46.10% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.90 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.71 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $1.26 | +1,884.13% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.69 | +195.86% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $3.65 | +3,187.67% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $12 | $0.98 | +1,126.18% | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $0.30 | +6,566.67% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $14.36 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $22.15 | -72.91% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $1.64 | +814.63% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $6.36 | +418.87% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $17.03 | -44.22% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $1.35 | +1,036,937.04% | 1 | Mar 5, 2020 |
Mirum Pharmaceuticals
Jan 13, 2026
Reiterates: Buy
Price Target: $81 → $102
Current: $93.27
Upside: +9.36%
Delcath Systems
Jan 9, 2026
Reiterates: Buy
Price Target: $30
Current: $10.34
Upside: +190.14%
Compugen
Jan 7, 2026
Initiates: Buy
Price Target: $4
Current: $2.11
Upside: +89.57%
Corcept Therapeutics
Jan 2, 2026
Maintains: Buy
Price Target: $145 → $90
Current: $36.31
Upside: +147.87%
Ekso Bionics Holdings
Dec 31, 2025
Downgrades: Neutral
Price Target: n/a
Current: $7.85
Upside: -
Pyxis Oncology
Dec 19, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $1.66
Upside: +321.69%
Absci
Dec 18, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $3.02
Upside: +164.90%
Janux Therapeutics
Dec 2, 2025
Maintains: Buy
Price Target: $70 → $45
Current: $13.27
Upside: +239.11%
MediWound
Nov 21, 2025
Maintains: Buy
Price Target: $31 → $36
Current: $17.07
Upside: +110.90%
Actuate Therapeutics
Nov 19, 2025
Reiterates: Buy
Price Target: $20
Current: $5.87
Upside: +241.01%
Nov 18, 2025
Maintains: Buy
Price Target: $13 → $4.5
Current: $0.70
Upside: +542.86%
Nov 17, 2025
Maintains: Buy
Price Target: $130 → $155
Current: $109.04
Upside: +42.15%
Nov 17, 2025
Downgrades: Neutral
Price Target: $77 → $94
Current: $107.16
Upside: -12.28%
Nov 14, 2025
Maintains: Buy
Price Target: $8.5 → $9
Current: $4.47
Upside: +101.34%
Nov 14, 2025
Maintains: Buy
Price Target: $55 → $32
Current: $18.08
Upside: +76.99%
Nov 11, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $9.65
Upside: +34.72%
Nov 10, 2025
Maintains: Buy
Price Target: $40 → $47
Current: $48.03
Upside: -2.14%
Nov 10, 2025
Maintains: Buy
Price Target: $3.5 → $5
Current: $3.75
Upside: +33.33%
Nov 4, 2025
Assumes: Buy
Price Target: $7,500
Current: $4.08
Upside: +183,723.53%
Oct 29, 2025
Upgrades: Buy
Price Target: $5
Current: $1.81
Upside: +176.24%
Oct 29, 2025
Maintains: Buy
Price Target: $9 → $22
Current: $6.60
Upside: +233.33%
Oct 23, 2025
Assumes: Buy
Price Target: $3
Current: $0.89
Upside: +237.76%
Oct 20, 2025
Reiterates: Buy
Price Target: $16
Current: $4.18
Upside: +282.78%
Aug 21, 2025
Reiterates: Buy
Price Target: $11
Current: $1.41
Upside: +680.14%
Aug 14, 2025
Reiterates: Neutral
Price Target: $15
Current: $2.76
Upside: +443.48%
Aug 12, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $0.98
Upside: +206.12%
Jun 24, 2025
Reiterates: Buy
Price Target: $7
Current: $1.49
Upside: +369.80%
May 29, 2025
Maintains: Buy
Price Target: $33 → $35
Current: $15.17
Upside: +130.72%
May 19, 2025
Reiterates: Buy
Price Target: n/a
Current: $1.23
Upside: -
May 19, 2025
Reiterates: Buy
Price Target: $3
Current: $1.00
Upside: +200.72%
May 9, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $1.47
Upside: +36.05%
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $1.54
Upside: +127.27%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $3.68
Upside: +416.30%
Mar 14, 2025
Maintains: Buy
Price Target: $240 → $180
Current: $2.33
Upside: +7,625.32%
Mar 13, 2025
Reiterates: Buy
Price Target: $25
Current: $7.58
Upside: +229.82%
Feb 28, 2025
Reiterates: Buy
Price Target: $60
Current: $37.72
Upside: +59.07%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $6.90
Upside: +378.26%
Nov 21, 2024
Reiterates: Buy
Price Target: $5
Current: $0.40
Upside: +1,159.45%
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $5.33
Upside: +106.38%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $5.57
Upside: +259.07%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $6.16
Upside: +46.10%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.90
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.71
Upside: -
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $1.26
Upside: +1,884.13%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $1.69
Upside: +195.86%
Nov 4, 2022
Maintains: Buy
Price Target: $90 → $120
Current: $3.65
Upside: +3,187.67%
Aug 15, 2022
Maintains: Buy
Price Target: $3 → $12
Current: $0.98
Upside: +1,126.18%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $0.30
Upside: +6,566.67%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $14.36
Upside: -
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $22.15
Upside: -72.91%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $1.64
Upside: +814.63%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $6.36
Upside: +418.87%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $17.03
Upside: -44.22%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $1.35
Upside: +1,036,937.04%